Discrepancies Between Pharmacokinetic Studies of Amitriptyline

Clinical Pharmacokinetics

Volumn 10, Issue 3, 1985, Pages 257-268

  Schulz, P ^a,d   Dick, P ^a   Blaschke, T F ^a,b   Hollister, L ^a,c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c Unit of the Palo Alto Veterans   (United States)

^d U de Psychopharmacologie Clin   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; NORTRIPTYLINE;

DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; LONG TERM CARE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; SHORT SURVEY; THERAPY;

AMITRIPTYLINE; DEPRESSIVE DISORDER; HALF-LIFE; HUMAN; KINETICS; MODELS, BIOLOGICAL; NORTRIPTYLINE;

EID: 0021956236     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-198510030-00005     Document Type: Review

References (43)

1. Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in man
2. Noncompartmental determination of the steady-state volume of distribution
3. Plasma protein binding of tricyclic antidepressants in man
4. Plasma concentration of amitriptyline and clinical response
5. Binding of tricyclic antidepressants and perazine to human plasma
6. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24-hour level in depressed patients
7. Reduced levels of tricyclic antidepressants in plasma from vacutainers
8. Amitriptyline pharmacokinetics — a crossover study with single doses of amitriptyline and nortriptyline
9. Binding of amitriptyline and nortriptyline in plasma determined from their equilibrium distributions between red cells and plasma, and between red cells and buffer solution
10. Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders
11. Single oral dose pharmacokinetics of amitriptyline and maprotiline in depressed patients — prediction of steady-state plasma concentrations
12. Amitriptyline dosage prediction in elderly patients from plasma concentration at 24 hours after a single 100mg dose
13. Apparent pharmacokinetic interaction of diazepam and amitriptyline in psychiatric patients: A pilot study
14. On the clinical response/serum level relationship for antidepressants. I: Amitriptyline
15. The kinetics of amitriptyline following single oral dose administration to man
16. A method for the determination of amitriptyline and its metabolites nortriptyline, 10-hydroxyamitriptyline, and 10-hy-droxynortriptyline in human plasma using stable isotope dilution and gas chromatography-chemical ionization mass spectrometry (GC-CIMS)
17. Premiers résultats d’une méthode originale de dosage des taux sériques d’antidépresseurs (amitriptyline et nortriptyline)
18. Pharmacokinetics of amitriptyline in the elderly
19. Plasma levels of a new pelletized form of amitriptyline for maintenance therapy
20. Comparative bioavailability of a sustained release preparation of amitriptyline and conventional tablets
21. Pharmacokinetics of amitriptyline infused intravenously in man
22. On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients
23. Amitriptyline plasma levels and clinical response in primary depression. Clin
24. Amitriptyline: Looking through the therapeutic window
25. Plasma and erythrocyte levels of tricyclic antidepressants in depressed patients
26. Effect of alcohol consumption and cigarette smoking on antidepressant levels of depressed patients
27. Single dose prediction of steady state plasma levels of amitriptyline
28. Amitriptyline metabolism: Relationship to polymorphic debrisoquine hydroxylation
29. Relationship between age and tricyclic antidepressant plasma levels
30. Age differences in effects on blood pressure, flicker fusion frequency, salivation and pharmacokinetics of single oral doses of dothiepin and amitriptyline
31. Tricyclic plasma levels in depressed outpatients treated with amitriptyline
32. Plasma tricyclic drug levels in amitriptyline-treated depressed patients
33. The half-life of Amitriptyline. Brit. J. Clin
34. Interindividual differences in amitriptyline demethylation
35. Biotransformation of amitriptyline in alcoholic depressive patients
36. Elimination and pharmacological effects following single oral doses of 50 and 75mg of amitriptyline in man
37. Amitriptyline disposition in young and elderly normal men. Clin. Pharmacol
38. A standard approach to compiling clinical pharmacokinetic data
39. Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline
40. Mesure de la concentration plasmatique et effet antidépresseur de l’amitriptyline
41. Contribution to the pharmacokinetics of amitriptyline